Indaptus Therapeutics Inc.

INDP | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.04

+$0.95 (+30.74%)

At close: Sep 22, 2026, 3:59 PM ET

$3.94

-$0.10 (-2.48%)

After-hours: Sep 22, 2026, 7:52 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $349.92M

Enterprise Value $338.36M

Beta 1.17

Average Volume 875.99K

Shares Outstanding (Diluted) 116.13M

Shares Change YoY 1915.64%

Institutional Ownership 0.06%

Exchange NASDAQ

ISIN US45339J2042

Price Performance

Price Change 1M 149.2%

Price Change 3M -16.7%

Price Change 6M 75.6%

Price Change YTD 12.8%

Price Change 1Y 8.8%

Price Change 3Y -95.9%

Price Change 5Y -98.8%

1M CAGR (ann.) 161.9%

1Y CAGR (ann.) 20.2%

5Y CAGR (ann.) -56.8%

All-Time CAGR -52.9%

Valuation

PE Ratio -0.57

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 30.77

P/FCF Ratio -23.05

P/Adj. FCF Ratio -21.69

P/OCF Ratio -23.77

EV/Sales N/A

EV/EBIT -21.90

EV/EBITDA -21.90

EV/FCF -22.29

Earnings Yield -176.4%

FCF Yield -4.3%

Adj. FCF Yield -4.6%

Financial Health

Net Cash $11.55M

Total Debt $0

Cash & Short-Term Investments $11.55M

Total Assets $11.99M

Current Ratio 19.48

Quick Ratio 19.48

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 328.03

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.3%

Returns

Return on Assets -128.7%

Return on Equity -302.8%

Return on Invested Capital -129.9%

Return on Capital Employed -129.9%

Return on Tangible Assets -128.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -56.7%

EPS CAGR 5Y -23.2%

EPS CAGR 10Y 33.9%

FCF CAGR 3Y -8.5%

FCF CAGR 5Y 0.9%

FCF CAGR 10Y 9.8%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 72.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 16, 2026

EPS Estimate (next Q) -$1.46

EPS Growth Est (next Q) -51.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-15.18M

Free Cash Flow $-15.18M

Adj. Free Cash Flow $-16.13M

FCF Per Share -$0.13

OCF Per Share -$0.13

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-14.77M

EBITDA $-15.45M

Net Income $-15.42M

EPS (Diluted) -$5.45

Revenue / Employee N/A

Profit / Employee $-3.08M

Employees 5